EKSO Q3 2025 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q3 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4M+2.4% YoY

Gross Profit

$3M60.3% margin

Operating Income

-$1M-33.2% margin

Net Income

-$1M-33.6% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

+105.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$259,000

Balance Sheet

Total Assets

$22M

Total Liabilities

$12M

Stockholders' Equity

$10M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+2.4%
Gross Profit	$3M	$2M	+15.4%
Operating Income	-$1M	-$3M	+46.9%
Net Income	-$1M	-$2M	+31.4%

Geographic Segments

Americas

$3M38%

UNITED STATES

$3M37%

EMEA

$791,0009%

Other Country

$428,0005%

FRANCE

$363,0004%

Asia Pacific

$253,0003%

APAC Other

$253,0003%

Americas Other

$22,0000%